Quantum Surgical receives FDA 510(k) clearance for the Epione® robot designed for cancer treatment
· Epione® is a unique robotic-assisted technology that can plan, target, deliver and confirm tumor ablation · Epione® aims to improve patients' lives by democratizing minimally invasive treatments through robotic-assisted procedures Montpellier, France, March 22, 2022 – Quantum Surgical, an innovative medical robotics company, announced today the US Food and Drug Administration (FDA) 510(k) clearance for Epione®, a new category of interventional oncology robotics dedicated to minimally invasive liver cancer treatment. "This clearance enables interventional oncologists to